VC
Vaccinex, Inc.
VCNX · OTC
$1.12 -1.75% (-$0.02)
1M +6.67%
Market Cap $3.05M
P/E Ratio -
Div. Yield -
ROE -
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Moderate
4/9Valuation
34 /100
Fair P/S 5.08x
EV/FFO N/A
P/E N/A
Growth
0 /100
Declining Rev. growth 12.59%
Book val. growth N/A
EPS growth N/A
Profitability
20 /100
Weak Op. margin 3,117.30%
Gross margin 95.51%
FCF margin 2,696.84%
Quality
61 /100
Average Asset turnover 0.23x
ROIC 760.66%
ROA 717.80%
Debt
3 /100
High Int. coverage -620.13x
Current ratio 0.50x
Debt/Assets N/A
Stability
52 /100
Moderate EPS volatility 19.97%
Beta 0.67x
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about VCNX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Maurice Zauderer
Employees
25
Headquarters
Rochester
Upcoming events
16 NOV
Earnings
Upcoming earnings report